OEM agreement

UgenTec and R-Biopharm's collaboration will cover the software's development, regulatory approval, and launch.

Horizon will supply cell-free DNA-based molecular reference standards for inclusion in CareDx’s cfDNA testing workflows for the monitoring of transplanted organ rejection.

The partners will work together to incorporate Horizon Discovery's genomic reference standards into Transgenomic's Multiplexed ICE COLD-PCR.

The partners will offer Horizon Discovery's reference materials as a standalone product to help validate ArcherDx's ALK fusion assays.

NEW YORK (GenomeWeb News) – Advion said on Monday it has signed an exclusive original equipment manufacturing and distribution partnership deal with Swiss firm CAMAG for Advion's TLC/MS interface product.

Sony DADC Biosciences, a business unit of Sony DADC that manufactures polymer-based consumables for in vitro diagnostic and biomedical research tool companies, this month opened its first US office in Cambridge, Mass.

NEW YORK (GenomeWeb News) – ZyGem today said that it has entered into an agreement with Quanta BioSciences to incorporate its enzymatic RNA-extraction technology into Quanta's quantitative PCR reagent kits.

This article has been corrected from a previous version that stated that Axxin disclosed in January that it is developing the NAT analyzer and iNAT platforms. In fact, Alere disclosed that it is developing these platforms.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – ZyGem today announced an original equipment manufacturing deal with Saudi Diagnostics for ZyGem's DNA and RNA extraction kits.

Pages

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.